Novo Nordisk confident of amycretin obesity drug launch this decade - dofaq.co
Novo Nordisk confident of amycretin obesity drug launch this decade
Reuters - 07 Mar 2024
Novo Nordisk is very comfortable it will be able to launch the pill version of its experimental weight loss drug amycretin this decade, the drugmaker's head ...
Ozempic maker Novo Nordisk facing pressure as study finds $1000 appetite suppressant can be made for just $5
Fortune - 28 Mar 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1000 appetite suppressant can be made for just $5 ...
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
CNBC - 27 Mar 2024
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests ...
Ozempic's cheaper side, weight loss drug competition, Amazon delivery
Quartz - 29 Mar 2024
Ozempic's cheaper side, weight loss drug competition, Amazon delivery ...
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
BioSpace - 28 Mar 2024
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy ...
Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices
The Hill - 27 Mar 2024
Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices ...
Bernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And Wegovy
Forbes - 27 Mar 2024
Bernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And Wegovy ...
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price
Bloomberg - 28 Mar 2024
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price ...
Novo Nordisk Under Fire, Post-Ozempic Study - TipRanks.com
TipRanks - 28 Mar 2024
Novo Nordisk Under Fire, Post-Ozempic Study - TipRanks.com ...
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Drugmakers Novo Nordisk And Eli Lilly Anytime Soon
Forbes - 27 Mar 2024
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Drugmakers Novo Nordisk And Eli Lilly Anytime Soon ...
Weight loss drugs firm expands into heart disease treatment
Euronews - 26 Mar 2024
Weight loss drugs firm expands into heart disease treatment ...
The Ozempic boom: How the entire country of Denmark became a company town
POLITICO Europe - 26 Mar 2024
The Ozempic boom: How the entire country of Denmark became a company town ...
Novo Nordisk strikes deal worth up to $1.1 bln to expand cardio business
Reuters - 25 Mar 2024
Novo Nordisk strikes deal worth up to $1.1 bln to expand cardio business ...
Novo Nordisk to buy Cardior, building up pipeline of heart drugs
STAT - 25 Mar 2024
Novo Nordisk to buy Cardior, building up pipeline of heart drugs ...
Latham Watkins Advises Novo Nordisk on Acquisition of Cardior Pharmaceuticals
Latham & Watkins LLP - 26 Mar 2024
Latham Watkins Advises Novo Nordisk on Acquisition of Cardior Pharmaceuticals ...
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
Yahoo Finance - 26 Mar 2024
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy? ...
Novo Nordisk to acquire Cardior Pharmaceuticals
mpg.de - 25 Mar 2024
Novo Nordisk to acquire Cardior Pharmaceuticals ...
Amycretin: Novo Nordisk's new rival to Wegovy in obesity treatment
Labiotech.eu - 27 Mar 2024
Amycretin: Novo Nordisk's new rival to Wegovy in obesity treatment ...
Novo Nordisk in €1bn deal for RNA-based heart disease therapies
Financial Times - 25 Mar 2024
Novo Nordisk in €1bn deal for RNA-based heart disease therapies ...
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price
Bloomberg - 28 Mar 2024
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price ...